Atlas Trials

Induced Pluripotent Stem Cells for the Development of Novel Drug Therapies for Inborn Errors of Metabolism (iPSC-IEM)

Clinical trial NCT04097275 · UNKNOWN

Trial details

NCT number
NCT04097275
Sponsor
CENTOGENE GmbH Rostock
Status
UNKNOWN
Study type
OBSERVATIONAL
Inborn Errors of Metabolism
Start date
2019-08-01
Primary completion
2024-08-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.